SCREENING FOR DEPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH THE BRITISH COLUMBIA MAJOR DEPRESSION INVENTORY

2002 ◽  
Vol 90 (3) ◽  
pp. 1091 ◽  
Author(s):  
GRANT L. IVERSON
Keyword(s):  
Systemic Lupus Erythematosus ◽  
British Columbia ◽  
Major Depression ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Major Depression Inventory

Screening for Depression in Systemic Lupus Erythematosus with the British Columbia Major Depression Inventory

2002 ◽  
Vol 90 (3_part_2) ◽  
pp. 1091-1096 ◽  
Author(s):  
Grant L. Iverson
Keyword(s):  
Systemic Lupus Erythematosus ◽  
British Columbia ◽  
Major Depression ◽  
Lupus Erythematosus ◽  
Community Control ◽  
Control Group ◽  
Systemic Lupus ◽  
Control Subjects ◽  
Major Depression Inventory ◽  
Falling Asleep

Accurate identification of depression in patients with systemic lupus erythematosus (SLE) is particularly complicated because the vegetative symptoms of depression also reflect core features of this autoimmune disease. Self-reported symptoms in patients with SLE ( n = 103) and community control subjects ( n = 136) were examined with the British Columbia Major Depression Inventory and the Beck Depression Inventory-II. The patients with lupus obtained higher scores on most items of the former inventory. A logistic regression analysis assessed whether a subset of these items were uniquely related to group membership. Clinically significant fatigue was much more common in patients with lupus than in the control group. Two items relating to sleep disturbance also entered the equation as unique predictors. The three-variable model resulted in 85% of the control subjects and 66% of the patients being correctly classified. A subset of patients with depression, according to the Beck inventory (17 or higher), were selected ( n = 41). Their most frequently endorsed symptoms on the British Columbia Inventory were fatigue (90.2%), trouble falling asleep (70.7%), cognitive difficulty (61%), and psychomotor slowing (58.5%). Only 29.3% reported significant sadness. 15% of these subjects were classified as not depressed, 46% as possibly depressed, and 39% as probably depressed on the British Columbia Inventory. It is advisable to assess whether patients are experiencing significant sadness or loss of interest before concluding that a high score on a screening test corresponds to probable depression.

Screening for Depression in Systemic Lupus Erythematosus with the British Columbia Major Depression Inventory

2002 ◽  
Vol 90 (3_suppl) ◽  
pp. 1091-1096 ◽  
Author(s):  
Grant L. Iverson
Keyword(s):  
Systemic Lupus Erythematosus ◽  
British Columbia ◽  
Major Depression ◽  
Lupus Erythematosus ◽  
Community Control ◽  
Control Group ◽  
Systemic Lupus ◽  
Control Subjects ◽  
Major Depression Inventory ◽  
Falling Asleep

Accurate identification of depression in patients with systemic lupus erythematosus (SLE) is particularly complicated because the vegetative symptoms of depression also reflect core features of this autoimmune disease. Self-reported symptoms in patients with SLE ( n = 103) and community control subjects ( n = 136) were examined with the British Columbia Major Depression Inventory and the Beck Depression Inventory–II. The patients with lupus obtained higher scores on most items of the former inventory. A logistic regression analysis assessed whether a subset of these items were uniquely related to group membership. Clinically significant fatigue was much more common in patients with lupus than in the control group. Two items relating to sleep disturbance also entered the equation as unique predictors. The three-variable model resulted in 85% of the control subjects and 66% of the patients being correctly classified. A subset of patients with depression, according to the Beck inventory (17 or higher), were selected ( n = 41). Their most frequently endorsed symptoms on the British Columbia Inventory were fatigue (90.2%), trouble falling asleep (70.7%), cognitive difficulty (61%), and psychomotor slowing (58.5%). Only 29.3% reported significant sadness. 15% of these subjects were classified as not depressed, 46% as possibly depressed, and 39% as probably depressed on the British Columbia Inventory. It is advisable to assess whether patients are experiencing significant sadness or loss of interest before concluding that a high score on a screening test corresponds to probable depression.

Parental Magico-Religious Illness Beliefs in an Adolescent Girl With Major Depression and Systemic Lupus Erythematosus

2006 ◽  
Vol 47 (1) ◽  
pp. 87-88 ◽  
Author(s):  
Olivier Taïeb ◽  
Olivier Bricou ◽  
Benoît Dutray ◽  
Anne Revah-Lévy ◽  
Tahar Abbal ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Major Depression ◽  
Lupus Erythematosus ◽  
Adolescent Girl ◽  
Illness Beliefs ◽  
Systemic Lupus

scholarly journals Association between Premenstrual Dysphoric Disorder and Systemic Lupus Erythematosus: Exacerbation of Major Depression Symptoms?

2013 ◽  
Vol 03 (04) ◽  
pp. 209-215
Author(s):  
Sílvia Fernanda Lima de Moura Cal ◽  
Lorena Cal Alonso ◽  
Amanda Galvão de Almeida ◽  
Mittermayer Barreto Santiago ◽  
Ângela Miranda-Scippa
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Major Depression ◽  
Lupus Erythematosus ◽  
Premenstrual Dysphoric Disorder ◽  
Depression Symptoms ◽  
Systemic Lupus

scholarly journals Canadian Rheumatology Association Meeting JW Marriott Parq Vancouver Vancouver, British Columbia, Canada February 21–24, 2018

2018 ◽  
Vol 45 (7) ◽  
pp. 964-1069 ◽  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
British Columbia ◽  
Lupus Erythematosus ◽  
Immune Modulation ◽  
Quality Care ◽  
Science Research ◽  
Diagnostic Tools ◽  
Original Research ◽  
Systemic Lupus ◽  
Young Faculty

The 73rd Annual Meeting of The Canadian Rheumatology Association (CRA) was held at the JW Marriott Parq Vancouver, Vancouver, British Columbia, Canada, February 21–24, 2018. The program consisted of presentations covering original research, symposia, awards, and lectures. Highlights of the meeting include the following 2018 award winners: Distinguished Rheumatologist, Alan Rosenberg; Distinguished Investigator, John Hanly; Teacher-Educator, Anna Oswald; Young Investigator, Évelyne Vinet; Best Abstract on Research by a Rheumatology Resident, May Choi; Best Abstract on Systemic Lupus Erythematosus Research by a Trainee – Ian Watson Award, Lily Wang; Best Abstract on Clinical or Epidemiology Research by a Trainee – Phil Rosen Award, Sophie Wojcik; Best Abstract on Basic Science Research by a Trainee, Jessica Salituri; Best Abstract on Quality Care Initiatives in Rheumatology, Arielle Mendel; Best Abstract by a Post-Graduate Research Trainee, Victoria Stefanelli; Best Abstract by a Medical Student, Tedi Qendro; Best Abstract by an Undergraduate Student, Sujay Nagaraj; Best Abstract on Research by Young Faculty, Kimberly Legault; Best Abstract on Pediatric Research by Young Faculty, Roberta Berard and Dax Rumsey. Lectures and other events included Keynote Address by John Hanly, Distinguished Investigator Awardee: Lupus and the Nervous System; Keynote Lecture by Linda Li: Arthritis Care in the Digital Age: The Patient CAN See you Now; State of the Art Lecture: Immunotherapy: Immune Modulation to Cure RA by Ranjeny Thomas; and the Great Debate: Be it Resolved that Precision Diagnostic Tools such as Biomarkers, Advanced Immunology, and Artificial Intelligence will Reduce the Need for Rheumatologists in the Future. Arguing for: Susa Benseler and Walter Maksymowych, and against: Trudy Taylor and Johannes Roth. Topics including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren syndrome, psoriatic arthritis, spondyloarthritis, vasculitis, osteoarthritis, fibromyalgia, and their respective diagnoses, treatments, and outcomes are reflected in the abstracts, which we are pleased to publish in this issue of The Journal.

scholarly journals Major depression and disease activity among systemic lupus erythematosus Egyptian females

2015 ◽  
Vol 37 (4) ◽  
pp. S1-S6 ◽  
Author(s):  
Hala Ahmed Raafat ◽  
Rasha M. El Refai ◽  
Heshmat A. Alrasheed ◽  
Mohamed Nasr El Din
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Major Depression ◽  
Disease Activity ◽  
Lupus Erythematosus ◽  
Systemic Lupus
Sign in / Sign up

Export Citation Format

Share Document